WASHINGTON (MedPage Today) -- Children with various polymorphisms in a critical metabolic pathway respond similarly to treatment with the antiretroviral drug efavirenz (Sustiva), researchers reported here at the International AIDS Conference. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Monday, 30 July 2012
Host Genotypes Have No Impact on Efavirenz in Kids (CME/CE)
WASHINGTON (MedPage Today) -- Children with various polymorphisms in a critical metabolic pathway respond similarly to treatment with the antiretroviral drug efavirenz (Sustiva), researchers reported here at the International AIDS Conference. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment